Connect with us
best Paper Writing service
mavi serum sipariş cialis sipariş hattı viagra siparişi pay vega 100 satın al


Regulating CBD oil – Forming an Internal Regulatory Team – The FDA announces a public hearing in May


Daniel Johnson who suffers from a connective tissue disease struggles with even the most basic tasks for a human body. He says his joints pop in and out of the sockets, and the process is excruciatingly painful. But CBD oil, or cannabidiol and medical marijuana has helped him overcome the pain.

Despite of the federal law legalizing hemp derived CBD, the Ohio Board of Pharmacy has banned the substance. CBD oil can be found only in state approved dispensaries which is making it difficult for patients to get their hands on it.

While Johnson uses medical marijuana and CBD oil to treat some of his symptoms, public asks for a clarification on the legality of CBD infused products, especially edibles by the U.S. Food and Drug Administration.

The FDA is yet to decide a regulatory framework for using CBD in food and drinks or as consumables. It will hold public hearing on May 31 to discuss about CBD and its potential effects. The agency will appoint an internal working group of people to regulate CBD products in the market and also check marketing of CBD supplements. Alongside, it will update the FAQ (frequently asked questions) section on its website and also put out warning letters for companies that are breaching the marketing policies with “egregious and unfounded claims”.

The agency has jointly sent out warning letters with the FTC to 3 companies for false marketing of their CBD products. Noah Miller says that he has witnessed the impact CBD oil can have on people, this is why he recommends the drug to his patients for chronic pain, seizures and even sickness while battling cancer to give it a shot which could possibly treat some of the symptoms.

However, Dr.Miller says that nobody should be making grand claims about the benefits of CBD until there is a recognized medical study to back them up. For companies admitting that their product infused with CBD can cure Alzheimer’s is just hurting the whole medical industry. False promises lead to elimination of trust from patients if not cured, unless there are medical proofs and substantial studies based on medical marijuana, no such claims should be made publicly.

According to Dr. Miller, one of the biggest problems with medical marijuana is the lack of research and knowledge in the subject. For decades, the compound has been listed under the Controlled Substance Act making it illegal to produce, distribute or possess. In fact, it was considered more dangerous than opioids.

The FDA approves only of one drug – Epidiolex containing CBD for treating patients suffering from severe epilepsy seizures. Other than that, the agency condemns CBD infused edibles or consumables in any manner till the time they clarify their grounds on the subject.

CBD is basically a chemical found in hemp plants, a cannabis genus plant which has anti-inflammatory properties. It helps reduce pain, swelling, inflammation and helps treat severe diseases such as Cancer. Cannabinoid is also a non-psychoactive component which means it does not alter the state of mind, unlike THC which triggers seizures, causes anxiety, disrupts sleeping patterns and lead to permanent mental disorders.

THC, tetrahydro cannabinoid is another compound found in marijuana plants which is a psychoactive component, responsible for the ‘high’ that people get while smoking weed. The federal law allows only 0.3% of THC in CBD based products, which is safe for human consumption without showing any side effects in later stage.

Ivan writes about Cannabis at The Cannabis Radar. He has a degree in Nutrition Sciences from University of Oklahoma Health Sciences Centre. He likes to spend his spare time reading to his daughter or spending time with his wife.

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *